Skip to main content
. 2018 Feb 12;2018:7154708. doi: 10.1155/2018/7154708

Figure 2.

Figure 2

Expression of biomarkers analyzed in blood from healthy women and patients with BC in phases I (before treatment) and II (after treatment). P  value ≤ 0.05 was considered significant between phase I and healthy women; ∗∗P  value ≤ 0.05 was considered significant between phase I and phase II.